Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi Secures Access to Salipro's Protein Stabilization Tech in R&D Deal
BioSpace
Tue, 11/8/22 - 10:25 pm
Tags:
Sanofi, Salipro, R&D
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Mon, 11/7/22 - 10:55 am
Tags:
Amgen, Repatha, patents, Supreme Court, Sanofi, Regeneron
Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators
Endpoints
Fri, 11/4/22 - 10:21 am
Tags:
Sanofi, AstraZeneca, RSV, nirsevimab, Europe, vaccines
Avanir, Strides are laying off US employees as Sanofi eyes early retirements in Korea: report
Fierce Pharma
Wed, 11/2/22 - 11:04 pm
Tags:
Avanir Pharmaceuticals, Strides Pharma, Sanofi, Korea, layoffs
Sanofi, Alnylam Q3 Reports Hint at Early Pipeline Impacts from IRA
BioSpace
Mon, 10/31/22 - 04:17 pm
Tags:
Sanofi, Alnylam, earnings, Inflation Reduction Act, legislation, drug pricing
Sanofi reveals setback for cancer drug acquired in Synthorx buyout
BioPharma Dive
Fri, 10/28/22 - 10:56 am
Tags:
Sanofi, Synthorx, M&A, SAR444245, cancer
Sanofi sees faster profit growth on Dupixent, flu vaccine demand
Yahoo/Reuters
Fri, 10/28/22 - 10:48 am
Tags:
Sanofi, earnings, Dupixent, vaccines
Sanofi and BioMed X Partner to Predict Efficacy with Virtual Patient Populations
BioSpace
Mon, 10/24/22 - 11:03 pm
Tags:
BioMed X, Sanofi, R&D, artificial intelligence, virtual patients
Sanofi, Regeneron team with Broadway actor for digital severe asthma program
Medical Marketing and Media
Wed, 10/19/22 - 10:54 pm
Tags:
asthma, severe asthma, Sanofi, Regeneron, pharma marketing
Novartis, GSK and Sanofi Scale Back on Operations and Labor Forces Overseas - Updated
BioSpace
Mon, 10/17/22 - 10:46 am
Tags:
Novartis, GSK, Sanofi, layoffs
J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules
Fierce Pharma
Thu, 10/13/22 - 11:50 pm
Tags:
i20 Therapeutics, Sanofi, JNJ, large molecule drugs
Dupixent Shows Promise as First Treatment for Childhood EoE
BioSpace
Wed, 10/12/22 - 10:33 am
Tags:
Dupixent, Sanofi, Regeneron, pediatric, clinical trials, eosinophilic esophagitis
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks, AbbVie, Alnylam, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, GSK, Intellia Therapeutics, Regeneron, Roche, Sanofi, Sarepta Therapeutics
Anticipating FDA Yes, Provention Inks Co-Promotion Deal with Sanofi for T1D Drug
BioSpace
Thu, 10/6/22 - 07:07 pm
Tags:
Provention Bio, Sanofi, type 1 diabetes, teplizumab
Sanofi, miRecule Ink Muscular Dystrophy Research Deal Worth up to $430M
BioSpace
Tue, 10/4/22 - 11:43 pm
Tags:
Sanofi, miRecule, myotonic muscular dystrophy
Sanofi licenses a preclinical genetic disease drug from an unknown biotech spun out of the NIH
Endpoints
Tue, 10/4/22 - 10:47 am
Tags:
Sanofi, antibody-RNA conjugate, miRecule, FSHD
FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis
Pharmaceutical Business Review
Thu, 09/29/22 - 10:05 am
Tags:
Sanofi, Regeneron, Dupixent, prurigo nodularis, FDA
Sanofi and Jennifer Doudna-Founded Scribe ink $1B CRISPR cell therapy deal
Pharma Live
Tue, 09/27/22 - 10:23 am
Tags:
Sanofi, Scribe Therapeutics, CRISPR, Jennifer Doudna, gene editing
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Tags:
Amgen, patents, Supreme Court, Repatha, Sanofi, Regeneron
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Fri, 09/16/22 - 10:54 am
Tags:
Sanofi, AstraZeneca, Pfizer, GSK, nirsevimab, Beyfortus, RSV

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.